YouTuber Pani Bottle has sparked interest after successfully losing weight by receiving the obesity treatment injection Wigobi.
On the 7th, a video titled "The Last Diet of a Man Who Has Been Severely Obese for 5 Years" was released on the YouTube channel Kwak Tube.
In the video, Kwak Tube met with Pani Bottle to hear about his experience after losing weight with Wigobi. He reported that he lost about 10 kg after receiving Wigobi, dropping from the 70 kg range to 64 kg.
Pani Bottle told Kwak Tube, "You should get Wigobi too. When I say that I lost weight by getting that injection, people accuse me of doing behind-the-scenes advertising, which is a bit unfair. They say it's behind-the-scenes advertising while I can't eat because of Wigobi, and I feel wronged. So now I am not talking about it anymore."
In January, Pani Bottle posted on social media (SNS), "What I learned from receiving Wigobi. I thought I was the type to gain weight even if I eat a little, but it turns out I was just eating a lot."
Wigobi, developed by the Danish pharmaceutical company Novo Nordisk, is a treatment that mimics the hormone GLP-1 which is released in our bodies when we eat. GLP-1 sends signals to the brain to indicate fullness, helps regulate stomach movement to prevent food from emptying too quickly, and assists in the release of insulin to lower blood sugar levels based on the blood sugar level. Thus, receiving Wigobi increases feelings of fullness and bloating, reducing appetite. It is also known as a drug that has been effectively used by Tesla CEO Elon Musk and famous broadcaster Oprah Winfrey.
In Korea, the targets for treatment are obese patients with a BMI of 30 or higher, as well as overweight patients with a BMI of 27 to 30 who have comorbid weight-related conditions such as hyperglycemia and hypertension. The price is set at 372,025 won per pen (4 weeks supply), but the consumer price forms around 500,000 to 800,000 won when adding distributor margins, taxes, and medical fees.